Laurence N. Charney

CIK: 0001407451

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (18.2%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (18.2%)

Compensation grants

Other (G, F, J, C, D, …)7 (63.6%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

TGTX

TG THERAPEUTICS, INC.

Director

KEN

Kenon Holdings Ltd.

Director

Discretionary Trading P&L

Holdings

Transaction History (11 total)

TGTX
TG THERAPEUTICS, INC.
Sep 10, 2026
Sale(S)
Direct
5K shares at avg. $54.96$275K
TGTX
TG THERAPEUTICS, INC.
Aug 7, 2026
Gift(G)
Direct
500 shares-
TGTX
TG THERAPEUTICS, INC.
Aug 7, 2026
Gift(G)
Direct
450 shares-
TGTX
TG THERAPEUTICS, INC.
Aug 6, 2026
Gift(G)
Direct
5.1K shares-
TGTX
TG THERAPEUTICS, INC.
Jun 11, 2026
Award(A)
Stock Tracking Unit
Direct
8.3K shares-
TGTX
TG THERAPEUTICS, INC.
Jan 29, 2026
Gift(G)
Direct
13.2K shares-
TGTX
TG THERAPEUTICS, INC.
Jan 28, 2026
Gift(G)
Direct
30K shares-
TGTX
TG THERAPEUTICS, INC.
Jun 12, 2025
Award(A)
Direct
21.4K shares-
TGTX
TG THERAPEUTICS, INC.
Mar 10, 2025
Gift(G)
Direct
6K shares-
TGTX
TG THERAPEUTICS, INC.
Nov 12, 2024
Gift(G)
Direct
5K shares-
TGTX
TG THERAPEUTICS, INC.
Nov 11, 2024
Sale(S)
Direct
25K shares at avg. $30.20$755K

		Type	Shares	Price		Ownership
Sep 10, 2026	TGTX TG THERAPEUTICS, INC.	Sale(S)	5,000	$54.96	$274,800	Direct
Aug 7, 2026	TGTX TG THERAPEUTICS, INC.	Gift(G)	500	-	$0	Direct
Aug 7, 2026	TGTX TG THERAPEUTICS, INC.	Gift(G)	450	-	$0	Direct
Aug 6, 2026	TGTX TG THERAPEUTICS, INC.	Gift(G)	5,100	-	$0	Direct
Jun 11, 2026	TGTX TG THERAPEUTICS, INC.	Award(A) Stock Tracking Unit	8,325	-	-	Direct
Jan 29, 2026	TGTX TG THERAPEUTICS, INC.	Gift(G)	13,197	-	$0	Direct
Jan 28, 2026	TGTX TG THERAPEUTICS, INC.	Gift(G)	30,000	-	$0	Direct
Jun 12, 2025	TGTX TG THERAPEUTICS, INC.	Award(A)	21,408	-	-	Direct
Mar 10, 2025	TGTX TG THERAPEUTICS, INC.	Gift(G)	6,000	-	-	Direct
Nov 12, 2024	TGTX TG THERAPEUTICS, INC.	Gift(G)	5,000	-	$0	Direct
Nov 11, 2024	TGTX TG THERAPEUTICS, INC.	Sale(S)	25,000	$30.20	$754,875	Direct

1-11 of 11 transactions

About Charney Laurence N

Charney Laurence N (SEC CIK 0001407451) files insider reports with the SEC as Director of TG THERAPEUTICS, INC. (TGTX) and Director of Kenon Holdings Ltd. (KEN).

Signal8 holds 8 ownership filings by Charney Laurence N (1 Form 3, 7 Form 4), filed between Nov 12, 2024 and Sep 14, 2026. Those filings report 11 transactions, from Nov 11, 2024 to Sep 10, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Charney Laurence N's filings is in MORRISVILLE, NC.

Recent filings by Charney Laurence N

Sep 10, 2026: Open-market sale of TGTX shares (Form 4, code S).
Aug 7, 2026: Gifts of TGTX shares (2 lines, Form 4, code G).
Aug 6, 2026: Gift of TGTX shares (Form 4, code G).
Jun 11, 2026: Grant or award of TGTX derivative securities (Form 4, code A).
Jan 29, 2026: Gift of TGTX shares (Form 4, code G).

Other insiders filing for TG THERAPEUTICS, INC. (TGTX)

Lonial Sagar, Director
HUME DANIEL, Director
Hoberman Kenneth, Director
Echelard Yann, Director
WEISS MICHAEL S, CEO
Power Sean A, CFO

How to read Form 4 transaction codes